This document provides an overview of breast anatomy, mammography techniques, mammogram findings, and clinical scenarios for breast imaging. It describes the three zones of breast anatomy and their relationships to chest wall structures. Mammography techniques discussed include basic projections, BI-RADS breast composition categories, and characteristics of masses, asymmetries, architectural distortions and calcifications. Clinical scenarios outlined the most appropriate imaging modalities for evaluating palpable lumps, discharge, pain, abnormal mammograms and assessing cancer treatment response.
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
Mammography
1. Dr.Bom B. C.
MD Radiognosis
NAMS, Bir Hospital
APPROACH TO
MAMMOGRAPHY
2. General breast anatomy
Conical, round or hemispherical shape.
Comprised of 15-20 lobes, each encased in
fascial sheath defined by AMF & PMF
Extends from 2nd or 3rd intercostal space to 6th
or 7th intercostal space
Extends laterally to anterior axillary fold and
medially to lateral sternum
3. Relationship to chest wall
Superior two-thirds overlies pectoralis major
muscle
Lateral portions overlies serratus anterior muscle
Inferior-most margin overlies upper
abdominaloblique muscles
Axillary tail of Spence: Extension of normal
breast tissue toward axilla.
4. ZONALANATOMY
Premammary (Subcutaneous) Zone
Most superficial zone.
Anterior margin defined by skin, posterior margin
defined by AMF.
Contains subcutaneous fat, blood vessels, anterior
suspensory (Cooper) ligaments, formed from two
leaflets of AMF inserting into dermis which provides
support for breast and is usually visible on
mammograms and sonograms.
5. Mammary Zone
Defined anteriorly by AMF and posteriorly by PMF
Contains majority of ducts/TDLUs (Terminal dust
lobular units), stromal fat and stromal connective
tissue
Subdivided haphazardly by interspersed ASLs.
Retromammary Zone
Most posterior of three zones
Defined anteriorly by PMF and posteriorly by chest
wall
Contains fat and PSLs which attach PMF to chest wall
6.
7. Mammograhy
Mammography is the radiographic examination of
the breast
tissue (soft tissue radiography).
To visualize normal structures and pathology
within the breast, it is essential that sharpness,
contrast and resolution are maximized.
This optimizes, in the image, the relatively small
differences in the absorption characteristics of the
structures comprising the breast.
A low kVp value, typically 28 kVp, is used.
Radiation dose must be minimized due to the
radio-sensitivity of breast tissue.
8. Mammography is carried out on both
symptomatic women with a known history or
suspected abnormality of the breast and as a
screening procedure in well, asymptomatic
woman.
Consistency of radiographic technique and image
quality is essential, particularly in screening
mammography, where comparison with former
films is often essential.
Other techniques such as magnetic resonance
imaging (MRI) and ultrasound have a role in
breast imaging, mammography is undertaken to
image the breast most commonly.
9. Basics of Screening Mammography
Performed in asymptomatic women aged 50 years
and over.
Performed in asymptomatic women aged 35 years and
over who have a high risk of developing breast cancer:
1. Women who have one or more first degree relatives
who have been diagnosed with premenopausal
breast cancer
2. Women with histological risk factors found at
previous surgery, e.g. atypical ductal hyperplasia
Two views of each breast (MLO and CC.)
Typically interpreted after patient has left the
department.
Normal (No recall) vs Abnormal (Recall).
10. Basics of Daignostics Mammography
Investigation of symptomatic women aged 35
years and over with a breast lump or other clinical
evidence of breast cancer( Discharge, skin
changes, constant focal pain etc.)
Surveillance of the breast following local excision
of breast carcinoma
Evaluation of a breast lump in women following
augmentation mammoplasty
Abnormal screening mammogram.
Investigation of a suspicious breast lump in a
man.
16. BI-RADS BREAST COMPOSITION
•The American College of Radiology Breast
Imaging and Reporting Database System
(BIRADS) divides breast composition into four
categories:
A. Almost entirely fat,
B. Scattered fibroglandular densities
(approximately 25-50% glandular),
C. Heterogeneously dense (51-75% glandular),
D. Extremely dense (greater than 75% glandular).
17.
18.
19. BI-RADS is designed to standardize breast
imaging reporting and to reduce confusion in
breast imaging interpretations.
It also facilitates outcome monitoring and quality
assessment.
It contains a lexicon for standardized terminology
(descriptors) for mammography, breast US and
MRI, as well as chapters on Report Organization
and Guidance Chapters for use in daily practice.
20.
21.
22. A 'Mass' is a space occupying 3D lesion seen in two different
projections.I f a potential mass is seen in only a single projection
it should be called a 'asymmetry' until its three-dimensionality
is confirmed.
27. Density
High
Iso
Low ( not fat)
Fat containing
Oil cysts
Lipoma
Galactocele
Hamartomas
Fibroadenolipomas
28.
29.
30.
31.
32. Skin Calcification
Vascular Calcification
Popcorn Calcification
Rod like Calcification
Lucent Centered Deposits
Eggshell/ Rim Calcification
Precipitated Calcification in milk of calcium.
Large Dystrophic Calcification
33. Skin Calcification
Tattoo Sign
Usually located along
inframammary fold parasternally,
Axilla and areola.
Can be seen in the skin
which is enface
36. Rod like calcification
Within ectatic ducts due
to secretory deposits
and follow ductal
distribution radiating
towards nipple.
May be continuous or
discontinuous and may
show branching.
Differentiate from
malignant fine branching
calcifications.
38. Eggshell or Rim Calcification
Wall of the Cyst.
Fat Necrosis.
Periphery of
Fibroadenoma
39. Milk of Calcium
Are benign sedimented calcification in
macro or micro cysts.
Typical feature is apparent change in
shape on different projections.
42. Amorphous or indistinct calcification
Calcification without a clearly
defined shape or form. They
are usually so small or hazy in
appearance, that a more
specific morphologic
classification can not be
determined.
Present in many benign and
malignant breast diseases.
About 10-20% of amorphous
calcifications turns out to be
malignant.
43. Coarse Heterogeneous Calcification
Irregular calcification
that are usually larger
than 0.5 mm but not
the size of large
heterogeneous
dystrophic
calcifications.
About 10-15% may
have risk of
malignancy.
44. Fine Pleomorphic:
• < 0.5 mm.
• Variable in size,
density or form
• 25 – 40% risk of
malignancy
45. Fine Linear or Branching
< 0.5mm in width.
Linear or branching distribution.
Risk of malignancy – 70%
49. Distribution of calcifications
The distribution of calcifications is also as important as
morphology. These descriptors are arranged according to
the risk of malignancy:
Diffuse: distributed randomly throughout the breast.
Regional: occupying a large portion of breast tissue > 2
cm greatest dimension
Grouped (historically cluster): few calcifications
occupying a small portion of breast tissue: lower limit 5
calcifications within 1 cm and upper limit a larger number
of calcifications within 2 cm.
Linear: arranged in a line, which suggests deposits in a
duct.
Segmental: suggests deposits in a duct or ducts and their
branches.
51. As compared to Malignant Calcification, Benign
Calcifications are:
Larger
Coarser
Round and smooth
Easily seen.
52.
53. In contrast to a mass, which is a 3-D structure
demonstrating convex outward borders and which is
usually evident on two orthogonal views, asymmetric
findings lack the convex outward borders and the
conspicuity typical of a mass.
54.
55. •If a potential mass is seen in only a single
view at standard mammography, it should be
called an “asymmetry” until its three-
dimensionality is confirmed.
• Approximately 80% of cases are due to
summation shadow, of normal fibroglandular
breast.
• True lesions may sometimes appear on only
one view because on other views they are
either obscured by overlapping dense
parenchyma or are located outside the field of
view.
56.
57. •Is seen in both the views.
•Involves a less than one quadrant of breast.
•It can be due to normal variations or some lesion.
58. •Is seen in both the views.
•Involves a greater volume of breast
tissue (at least a quadrant)
•Without any associated mass
suspicious calcifications, or
architectural distortions.
• It is usually due to normal
variations or hormonal influence and
only significant when it corresponds
to a palpable abnormality.
59.
60. This is a focal asymmetry that is new,
larger, or denser at current examination
than at previous examinations.
61.
62.
63. •Well circumscribed.
• < 1cm
• Upper and outer quadrant
• Lucent and invaginated
fatty hilum.
•May appear as 3 or more
round densities in horse
shoe arrangement.
64. •If a mass is seen in a section other than upper and
outer quadrant, unless it has a clearly defined hilum.
• Lesion in upper outer quadrant does not have
other characteristics, it should be considered
suspicious as malignant node or primary mass.
65.
66. Tubular or branching
structure
representing
dilated duct.
Usually of minor
significance.
BIRADS III
67.
68. Spiculations radiating
from a point without
any
identifiable mass.
The only
architectural
distortion that does not
require further
evaluation is that
caused
by prior surgery or
trauma.
71. Architectural distortion(Parenchymal
distortion/Stellate lesion)
An area of architectural distortion of the breast is seen
mammographically as numerous straight lines usually
measuring from 1 to 4 cm in length radiating toward a
central area .
The central part of the lesion typically shows no
central soft-tissue mass either on standard or
localized compression views.
A mammographic work-up including repeat standard
views and, where necessary, localized compression
views should be performed to confirm that a stellate
lesion is present rather than a density with apparent
architectural distortion caused by summation of
normal overlying stromal shadows , and to look for
associated signs such as microcalcifications.
72. A. Stellate appearance (arrows) due to summation of
overlying stromal shadows. B. Repeat film shows that no
lesion is present.
A B
73. Stellate opacity due to a
surgical scar.
Stellate lesion due to an invasive tubular carcino
74. FINALLY WE HAVE to decide on the significance of
the mammographic findings.
FINALISE THE REPORT IN 7 SPECIFIC
CATEGORIES.
75.
76.
77. Mammography
Strengths Weakness
Provides overview of both
breasts.
Not operator dependent-
reproducible
Only proven modality for
screening.
Shows
microcalcifications.
Best modality for showing
spiculations.
Not effective in dense
breasts.
Difficult to differentiate
cyst vs solid
Radiation exposure.
78. Ultrasound
Strenghts Weakness
Excellent at showing masses.
Differentiates cyst vs solids.
High reliabilty in telling
normal tissue from a mass.
Best modality to correlate a
lump to imaging.
Easiest method for biopsy.
Least expensive equipment,
readily available, radiation
free
Operator dependent.
Coverage is dependent
on technique.
Usually may miss
calcifications.
79. MRI
Strengths Weakness
Most sensitive modality
(Best modality for
detecting cancers).
Not dependent on shape
and margin.
Not affected by dense
breast tissue
Most expensive, readily
not available.
Background enhancement
decreases sensitivity.
Can miss low grade DCIS
presenting as
calcifications.
Subject to False positives
as benign masses and
normal tissue can
enhance.
80. Clinical scenarios
A. Palpable abnormality (Lump)
1. USG is absolute mandatory.
2. Mammography is less useful- Good for screening for
the rest of breast.
B. Discharge
1. Subareolar USG to look for dilated duct and intra-ductal
mass.
2. Mammography to look for calcifications.
3. Ductography.
81. C. Pain
1. Only needs work up if focal and constant
2. USG more useful followed by mammography.
D. Abnormal Mammogram
1. Asymmetry, distortion- Spot compression
mammography and additional projections, do USG if
looks real.
2. Mass- USG, first do additional mammography views
if needed to localize the abnormality.
3. Calcifications- Mammography, most are not seen by
USG, Can try USG as it can be used in biopsy
82. E. Known cancer
1. MRI is best for assessing size of tumor and extent of
disease, other lesions, chest cell invasion, lymph
node.
2. USG is also good for looking the extent of the
disease- can guide biopsy- can evaluate the axilla.
3. Mammography for seeing extent of calcifications.
F. Chemotherapy response.
MRI is best modality for assessing for response to
neo-adjuvent chemotherapy.
83.
84.
85.
86.
87. References
Clark’s Positioning in Radiography
Textbook of Radiology and Imaging- David
Sutton, Volume 2
Diagnostic workflow in Imaging: Mammogaphy,
Ultrasound, MRI, Biopsy : John Lewin
Radioassistant